相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High glucose contributes to the proliferation and migration of non-small-cell lung cancer cells via GAS5-TRIB3 axis
Cheng-Zhi Ding et al.
BIOSCIENCE REPORTS (2018)
Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osimertinib
Shengwu Liu et al.
CLINICAL CANCER RESEARCH (2018)
Cetuximab for treating non-small cell lung cancer
Luca Mazzarella et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
The ERBB network facilitates KRAS-driven lung tumorigenesis
Bjorn Kruspig et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR
J. Hou et al.
ONCOGENE (2017)
Diversity-Oriented Stapling Yields Intrinsically Cell-Penetrant Inducers of Autophagy
Leila Peraro et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer
Hatim Husain et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway
Jin Su et al.
ONCOLOGY REPORTS (2017)
MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells
K. R. Jakobsen et al.
ONCOGENESIS (2017)
TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence
Ke Li et al.
CANCER CELL (2017)
Amplification of EGFR Wild-Type Alleles in Non-Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors
Shigenari Nukaga et al.
CANCER RESEARCH (2017)
The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase
Tatiana Erazo et al.
CLINICAL CANCER RESEARCH (2016)
Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer
Debasis Mondal et al.
BIOCHIMIE (2016)
GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis
Qing-Hai Ye et al.
CANCER CELL (2016)
Stress-induced endocytosis and degradation of epidermal growth factor receptor are two independent processes
Ke Peng et al.
CANCER CELL INTERNATIONAL (2016)
Lung cancer stem cells: The root of resistance
Lauren MacDonagh et al.
CANCER LETTERS (2016)
Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
Toshimitsu Yamaoka et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
Yong Jia et al.
NATURE (2016)
Cancer stem cells and chemoresistance: The smartest survives the raid
Jihe Zhao
PHARMACOLOGY & THERAPEUTICS (2016)
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
Piro Lito et al.
SCIENCE (2016)
Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications
Xiaojun Tan et al.
TRENDS IN CELL BIOLOGY (2016)
EGFR as a Pharmacological Target in EGFR-Mutant Non-Small-Cell Lung Cancer: Where Do We Stand Now?
E-E Ke et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State
Matthew P. Patricelli et al.
CANCER DISCOVERY (2016)
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
Kenneth S. Thress et al.
NATURE MEDICINE (2015)
Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer
L. V. Sequist et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
I-TASSER server: new development for protein structure and function predictions
Jianyi Yang et al.
NUCLEIC ACIDS RESEARCH (2015)
Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma
Tapan K. Maity et al.
CANCER DISCOVERY (2015)
The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy
Fiona H. Tan et al.
CURRENT DRUG TARGETS (2014)
Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a toll-like receptor 2-mediated cell-penetrating peptide
Ke Li et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Pellino 1 promotes lymphomagenesis by deregulating BCL6 polyubiquitination
Hye-Young Park et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Localized light-induced protein dimerization in living cells using a photocaged dimerizer
Edward R. Ballister et al.
NATURE COMMUNICATIONS (2014)
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
Darren A. E. Cross et al.
CANCER DISCOVERY (2014)
Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells
Tianliang Li et al.
AUTOPHAGY (2013)
Protein tyrosine kinase regulation by ubiquitination: Critical roles of Cbl-family ubiquitin ligases
Bhopal Mohapatra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
Helena A. Yu et al.
CLINICAL CANCER RESEARCH (2013)
The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor
Christopher J. Smith et al.
JOURNAL OF CELL SCIENCE (2013)
Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC
Hideki Terai et al.
MOLECULAR CANCER RESEARCH (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Sustained Activation of Protein Kinase C Induces Delayed Phosphorylation and Regulates the Fate of Epidermal Growth Factor Receptor
Mengling Liu et al.
PLOS ONE (2013)
Stapled α-helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
Yong S. Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Targeting C4-Demethylating Genes in the Cholesterol Pathway Sensitizes Cancer Cells to EGF Receptor Inhibitors via Increased EGF Receptor Degradation
Anna Sukhanova et al.
CANCER DISCOVERY (2013)
IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations
Alejandro Vazquez-Martin et al.
SCIENTIFIC REPORTS (2013)
Hypoxia regulation of phosphokinases and the prognostic value of pAKT in breast cancer
Marloes Wennemers et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2013)
WWP1: a versatile ubiquitin E3 ligase in signaling and diseases
Xu Zhi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
The Mammalian Tribbles Homolog TRIB3, Glucose Homeostasis, and Cardiovascular Diseases
Sabrina Prudente et al.
ENDOCRINE REVIEWS (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Spatial regulation of receptor tyrosine kinases in development and cancer
Jessica B. Casaletto et al.
NATURE REVIEWS CANCER (2012)
Recycling of the Epidermal Growth Factor Receptor Is Mediated by a Novel Form of the Clathrin Adaptor Protein Eps15
Susan Chi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
A direct role for Met endocytosis in tumorigenesis
Carine Joffre et al.
NATURE CELL BIOLOGY (2011)
Regulation of EGFR Protein Stability by the HECT-type Ubiquitin Ligase SMURF2
Dipankar Ray et al.
NEOPLASIA (2011)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
Chunaram Choudhary et al.
MOLECULAR CELL (2009)
Survival of cancer cells is maintained by EGFR independent of its kinase activity
Zhang Weihua et al.
CANCER CELL (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11
C. Chen et al.
ONCOGENE (2008)
The age of crosstalk: Phosphorylation, ubiquitination, and beyond
Tony Hunter
MOLECULAR CELL (2007)
A structural model for the membrane-bound form of the juxtamembrane domain of the epidermal growth factor receptor
K Choowongkomon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death
N Ohoka et al.
EMBO JOURNAL (2005)
Nuclear localization of EGF receptor and its potential new role as a transcription factor
SY Lin et al.
NATURE CELL BIOLOGY (2001)
Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome
J Bao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
